Lhatoo, Samden D.
(Epilepsy Research Group, Institute of Neurology, University College London, London, United Kingdom)
,
Johnson, Anthony L.
(MRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom)
,
Goodridge, David M.
(Warders Medical Centre, Tonbridge, Kent, United Kingdom)
,
MacDonald, Bridget K.
(Epilepsy Research Group, Institute of Neurology, University College London, London, United Kingdom)
,
Sander, Josemir W. A. S.
(Epilepsy Research Group, Institute of Neurology, University College London, London, United Kingdom)
,
Shorvon, Simon D.
(Epilepsy Research Group, Institute of Neurology, University College London, London, United Kingdom)
The United Kingdom National General Practice Study of Epilepsy is a prospective, population-based study of newly diagnosed epilepsy. A cohort of 792 patients has now been followed for up to 14 years (median follow-up [25th, 75th percentiles] 11.8 years, range 10.6–11.7 years), a total of 11,40...
The United Kingdom National General Practice Study of Epilepsy is a prospective, population-based study of newly diagnosed epilepsy. A cohort of 792 patients has now been followed for up to 14 years (median follow-up [25th, 75th percentiles] 11.8 years, range 10.6–11.7 years), a total of 11,400 person-years. These data are sufficient for a detailed analysis of mortality in this early phase of epilepsy. Over 70% of patients in this cohort have developed lasting remission from seizures, although the mortality rate in the long term was still twice that of the general population. The standardized mortality ratio (SMR), the number of observed deaths per number of expected deaths, was 2.1 (95% confidence interval [CI] = 1.8, 2.4). Patients with acute symptomatic epilepsy (SMR 3.0; 95% CI = 2.0, 4.3), remote symptomatic epilepsy (SMR 3.7; 95% CI = 2.9, 4.6), and epilepsy due to congenital neurological deficits (SMR 25; 95% CI = 5.1, 73.1) had significantly increased long-term mortality rates, whereas patients with idiopathic epilepsy did not (SMR 1.3; 95% CI = 0.9, 1.9). This increase in mortality rate was noted particularly in the first few years after diagnosis. Multivariate Cox regression and time-dependent co-variate analyses were utilized for the first time in a prospective study of mortality in epilepsy. The former showed that patients with generalized tonic-clonic seizures had an increased risk of mortality. The hazard ratio (HR), or risk of mortality in a particular group with a particular risk factor compared to another group without that particular risk factor, was 6.2 (95% CI = 1.4, 27.7; p = 0.049). Cerebrovascular disease (HR 2.4; 95% CI = 1.7, 3.4; p < 0.0001), central nervous system tumor (HR 12.0; 95% CI = 7.9, 18.2; p < 0.0001), alcohol (HR 2.9; 95% CI = 1.5, 5.7; p = 0.004), and congenital neurological deficits (HR 10.9; 95% CI = 3.2, 36.1; p = 0.003) as causes for epilepsy and older age at index seizure (HR 1.9; 95% CI = 1.7,2.0; p < 0.0001) were also associated with significantly increased mortality rates. These hazard ratios suggest that epilepsy due to congenital neurological deficits may carry almost the same risk of mortality as epilepsy due to central nervous system tumors and that epileptic seizures subsequent to alcohol abuse may carry almost the same risk of mortality as epilepsy due to cerebrovascular disease. The occurrence of one or more seizures before the index seizure (the seizure that led to the diagnosis of epilepsy and enrolment in the study) was associated with a significantly reduced mortality rate (HR 0.57; 95% CI = 0.42, 0.76; p = 0.00001). Time-dependent co-variate analysis was used to examine the influence of ongoing factors, such as seizure recurrence, remission, and antiepileptic drug use, on mortality rates in the cohort. Seizure recurrence (HR 1.30; 95% CI = 0.84, 2.01) and antiepileptic drug treatment (HR 0.97; 95% CI = 0.67, 1.38) did not influence mortality rate. There were only 5 epilepsy-related deaths (1 each of sudden unexpected death in epilepsy, status epilepticus, burns, drowning, and cervical fracture), suggesting that death directly due to epileptic seizures is uncommon in a population-based cohort with epilepsy. Ann Neurol 2001;49:336–344
The United Kingdom National General Practice Study of Epilepsy is a prospective, population-based study of newly diagnosed epilepsy. A cohort of 792 patients has now been followed for up to 14 years (median follow-up [25th, 75th percentiles] 11.8 years, range 10.6–11.7 years), a total of 11,400 person-years. These data are sufficient for a detailed analysis of mortality in this early phase of epilepsy. Over 70% of patients in this cohort have developed lasting remission from seizures, although the mortality rate in the long term was still twice that of the general population. The standardized mortality ratio (SMR), the number of observed deaths per number of expected deaths, was 2.1 (95% confidence interval [CI] = 1.8, 2.4). Patients with acute symptomatic epilepsy (SMR 3.0; 95% CI = 2.0, 4.3), remote symptomatic epilepsy (SMR 3.7; 95% CI = 2.9, 4.6), and epilepsy due to congenital neurological deficits (SMR 25; 95% CI = 5.1, 73.1) had significantly increased long-term mortality rates, whereas patients with idiopathic epilepsy did not (SMR 1.3; 95% CI = 0.9, 1.9). This increase in mortality rate was noted particularly in the first few years after diagnosis. Multivariate Cox regression and time-dependent co-variate analyses were utilized for the first time in a prospective study of mortality in epilepsy. The former showed that patients with generalized tonic-clonic seizures had an increased risk of mortality. The hazard ratio (HR), or risk of mortality in a particular group with a particular risk factor compared to another group without that particular risk factor, was 6.2 (95% CI = 1.4, 27.7; p = 0.049). Cerebrovascular disease (HR 2.4; 95% CI = 1.7, 3.4; p < 0.0001), central nervous system tumor (HR 12.0; 95% CI = 7.9, 18.2; p < 0.0001), alcohol (HR 2.9; 95% CI = 1.5, 5.7; p = 0.004), and congenital neurological deficits (HR 10.9; 95% CI = 3.2, 36.1; p = 0.003) as causes for epilepsy and older age at index seizure (HR 1.9; 95% CI = 1.7,2.0; p < 0.0001) were also associated with significantly increased mortality rates. These hazard ratios suggest that epilepsy due to congenital neurological deficits may carry almost the same risk of mortality as epilepsy due to central nervous system tumors and that epileptic seizures subsequent to alcohol abuse may carry almost the same risk of mortality as epilepsy due to cerebrovascular disease. The occurrence of one or more seizures before the index seizure (the seizure that led to the diagnosis of epilepsy and enrolment in the study) was associated with a significantly reduced mortality rate (HR 0.57; 95% CI = 0.42, 0.76; p = 0.00001). Time-dependent co-variate analysis was used to examine the influence of ongoing factors, such as seizure recurrence, remission, and antiepileptic drug use, on mortality rates in the cohort. Seizure recurrence (HR 1.30; 95% CI = 0.84, 2.01) and antiepileptic drug treatment (HR 0.97; 95% CI = 0.67, 1.38) did not influence mortality rate. There were only 5 epilepsy-related deaths (1 each of sudden unexpected death in epilepsy, status epilepticus, burns, drowning, and cervical fracture), suggesting that death directly due to epileptic seizures is uncommon in a population-based cohort with epilepsy. Ann Neurol 2001;49:336–344
참고문헌 (21)
The prognosis of patients with epilepsy Rodin EA 1968
O'Donoghue, M. F., Sander, J. W. A. S..
A historical perspective on the mortality associated with chronic epilepsy.
Acta neurologica Scandinavica,
vol.96,
no.3,
138-141.
Hauser, W. Allen, Annegers, John F., Elveback, Lila R..
Mortality in Patients with Epilepsy.
Epilepsia : the journal of the International League against Epilepsy,
vol.21,
no.4,
399-412.
National General Practice Study of Epilepsy and Epileptic Seizures: Objectives and Study Methodology of the Largest Reported Prospective Cohort Study of Epilepsy.
Neuroepidemiology,
vol.8,
no.5,
221-227.
Sander, J.W.A.S., Hart, Y.M., Shorvon, S.D., Johnson, A.L..
MEDICAL SCIENCE - National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population.
The Lancet,
vol.336,
no.8726,
1267-1271.
Person years (PYRS): a further program for cohort study analysis Coleman MP 1989
BMDP statistical software manual Dixon WJ 1992
Sillanpää, Matti, Jalava, Merja, Kaleva, Olli, Shinnar, Shlomo.
Long-Term Prognosis of Seizures with Onset in Childhood.
The New England journal of medicine,
vol.338,
no.24,
1715-1722.
Olafsson, Elias, Allen Hauser, W., Gudmundsson, Gunnar.
Long‐Term Survival of People with Unprovoked Seizures: A Population‐Based Study.
Epilepsia : the journal of the International League against Epilepsy,
vol.39,
no.1,
89-92.
Nilsson, Lena, Tomson, T., Farahmand, B. Y., Diwan, V., Persson, P. G..
Cause‐Specific Mortality in Epilepsy: A Cohort Study of More Than 9,000 Patients Once Hospitalized for Epilepsy.
Epilepsia : the journal of the International League against Epilepsy,
vol.38,
no.10,
1062-1068.
Shackleton, D P, Westendorp, R G J, Trenite, D G A K.-N., Vandenbroucke, J P.
Mortality in patients with epilepsy: 40 years of follow up in a Dutch cohort study.
Journal of neurology, neurosurgery, and psychiatry,
vol.66,
no.5,
636-640.
Zielihski, Janusz J..
Epilepsy and Mortality Rate and Cause of Death.
Epilepsia : the journal of the International League against Epilepsy,
vol.15,
no.2,
191-201.
Cockerell, Oliver C., Johnson, Anthony L., Sander, Josemir W. A. S., Shorvon, Simon D..
Prognosis of Epilepsy: A Review and Further Analysis of the First Nine Years of the British National General Practice Study of Epilepsy, a Prospective Population‐Based Study.
Epilepsia : the journal of the International League against Epilepsy,
vol.38,
no.1,
31-46.
Everitt, A. D, Sander, J. W.
Incidence of epilepsy is now higher in elderly people than children.
BMJ : British medical journal,
vol.316,
no.7133,
780-780.
LHATOO, S D, LANGAN, Y, MACDONALD, B K, ZEIDAN, S, SANDER, J W A S.
Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates.
Journal of neurology, neurosurgery, and psychiatry,
vol.66,
no.5,
692-693.
Nashef, L, Fish, D R, Sander, J W, Shorvon, S D.
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre..
Journal of neurology, neurosurgery, and psychiatry,
vol.58,
no.4,
462-464.
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.